Intra-tumor persistence of activated anti-mesothelin hYP218 CAR T cells is associated with increased efficacy in gastric and colorectal cancers

被引：0
|
作者：
Mir, Sameer A.
Venugopalan, Abhilash
Zhang, Jingli
Khanal, Mana Kamana
Stathopoulou, Chaido
Sengupta, Manjistha
Jiang, Qun
Hassan, Raffit
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-62
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62
引用
收藏
页数：2
相关论文
共 3 条
  • [1] Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors
    Tomar, Sakshi
    Zhang, Jingli
    Khanal, Manakamana
    Hong, Jessica
    Venugopalan, Abhilash
    Jiang, Qun
    Sengupta, Manjistha
    Miettinen, Markku
    Li, Nan
    Pastan, Ira
    Ho, Mitchell
    Hassan, Raffit
    [J]. MOLECULAR CANCER THERAPEUTICS, 2022, 21 (07) : 1195 - 1206
  • [2] hYP218 CAR-T cells targeting a membrane-proximal epitope of mesothelin are highly effective against mesothelin expressing cancers
    Tomar, Sakshi
    Zhang, Jingli
    Li, Nan
    Pastan, Ira
    Ho, Mitchell
    Hassan, Raffit
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [3] CXCR6 EXPRESSION ENHANCES ACCUMULATION OF ANTI-MESOTHELIN CAR T CELLS AT THE TUMOR SITE AND THEIR THERAPEUTIC EFFICACY IN PANCREATIC CANCER XENOGRAFTS
    Stoiber, S.
    Lesch, S.
    Ogonek, J.
    Cadilha, B.
    Benmebarek, M.
    Gottschlich, A.
    Metzger, P.
    Hoerth, C.
    Nottebrock, A.
    Endres, S.
    Kobold, S.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A44 - A44
1